These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4598256)

  • 21. [Production of humoral antibodies to salmonella Vi-, H- I and O-antigens in mice preliminarily treated with a cytoplasmic fraction from E. coli].
    Stanislavskiĭ ES; Kirpatovskiĭ ID; Levina LA; Bogdanova VV; Eltonskaia GA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Feb; (2):123-8. PubMed ID: 4616561
    [No Abstract]   [Full Text] [Related]  

  • 22. The PhoP virulence regulon and live oral Salmonella vaccines.
    Miller SI; Loomis WP; Alpuche-Aranda C; Behlau I; Hohmann E
    Vaccine; 1993; 11(2):122-5. PubMed ID: 8438611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains.
    Zhang X; Kelly SM; Bollen W; Curtiss R
    Microb Pathog; 1999 Mar; 26(3):121-30. PubMed ID: 10089152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenic complexes obtained from Salmonella typhi-murium and Salmonella typhi Ty2 by the bacterial acetone powder method.
    Tato P; Flisser A; Gavilanes M; Molinari JL
    Ann Microbiol (Paris); 1979 Jan; 130 A(1):47-60. PubMed ID: 382951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Salmonella porins as a broad spectrum vaccine candidate.
    Tabaraie B; Sharma BK; Sharma PR; Sehgal R; Ganguly NK
    Microbiol Immunol; 1994; 38(7):553-9. PubMed ID: 7968689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunity conferred by Aro- Salmonella live vaccines.
    Hormaeche CE; Joysey HS; Desilva L; Izhar M; Stocker BA
    Microb Pathog; 1991 Feb; 10(2):149-58. PubMed ID: 1890952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of host resistance to Salmonella typhi and Salmonella typhimurium: bacterial survival within macrophages of murine and human origin.
    Vladoianu IR; Chang HR; Pechère JC
    Microb Pathog; 1990 Feb; 8(2):83-90. PubMed ID: 2190062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ribonucleic acid-protein fractions of virulent Salmonella typhimurium as protective immunogens.
    Smith RA; Bigley NJ
    Infect Immun; 1972 Sep; 6(3):377-83. PubMed ID: 4564892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens.
    Mastroeni P; Simmons C; Fowler R; Hormaeche CE; Dougan G
    Infect Immun; 2000 Jan; 68(1):46-53. PubMed ID: 10603367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against Salmonella typhi infection in mice after immunization with outer membrane proteins isolated from Salmonella typhi 9,12,d, Vi.
    Isibasi A; Ortiz V; Vargas M; Paniagua J; González C; Moreno J; Kumate J
    Infect Immun; 1988 Nov; 56(11):2953-9. PubMed ID: 2844676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aroA, Salmonella typhi Ty21a, and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit.
    Walker MJ; Rohde M; Timmis KN; Guzmán CA
    Infect Immun; 1992 Oct; 60(10):4260-8. PubMed ID: 1398937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of H-antigen in postvaccinal immunity against typhoid and paratyphoid].
    Kheĭfets LB; Stanislavskiĭ ES; Levina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1974; 00(5):113-4. PubMed ID: 4218035
    [No Abstract]   [Full Text] [Related]  

  • 34. Control of colonization by virulent Salmonella typhimurium by oral immunization of chickens with avirulent delta cya delta crp S. typhimurium.
    Hassan JO; Curtiss R
    Res Microbiol; 1990; 141(7-8):839-50. PubMed ID: 2101473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purified Vi antigens as possible typhoid vaccines.
    Pistole TG; Marcus S
    Immunol Commun; 1974; 3(3):227-38. PubMed ID: 4606971
    [No Abstract]   [Full Text] [Related]  

  • 36. [Protective properties of Vi-antigen preparations as dependent on their adhesin content].
    Alliluev AP; Kotel'nikova OV; Korneeva SA; Fish NG; Kulinich LI
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):21-6. PubMed ID: 2469269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antigenic structure of Salmonella L forms studied by an immunoferritin method].
    Prozorovskiĭ SV; Kirillova FM; Stepanova LK; Gorelov AL; Levina GA
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):24-6. PubMed ID: 2409718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two Novel
    Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
    Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Separate transfer of mouse protection and delayed-type hypersensitivity with Salmonella typhimurium transfer factor.
    Kita E; Matsuda Y; Matsuda K; Kashiba S
    Cell Immunol; 1984 Sep; 87(2):528-37. PubMed ID: 6380767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium.
    Svenson SB; Nurminen M; Lindberg AA
    Infect Immun; 1979 Sep; 25(3):863-72. PubMed ID: 387597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.